CW Advisors LLC Purchases New Stake in Encompass Health Corporation $EHC

CW Advisors LLC acquired a new position in shares of Encompass Health Corporation (NYSE:EHC) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 109,643 shares of the company’s stock, valued at approximately $13,446,000. CW Advisors LLC owned 0.11% of Encompass Health as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. WPG Advisers LLC purchased a new stake in Encompass Health during the 1st quarter worth $27,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of Encompass Health by 749.0% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock worth $42,000 after buying an additional 367 shares during the period. Employees Retirement System of Texas purchased a new stake in shares of Encompass Health during the 2nd quarter valued at about $57,000. Parkside Financial Bank & Trust lifted its position in Encompass Health by 179.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock worth $59,000 after acquiring an additional 307 shares in the last quarter. Finally, Park Place Capital Corp purchased a new position in Encompass Health in the 2nd quarter worth approximately $72,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Performance

Shares of Encompass Health stock opened at $113.02 on Thursday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.14. Encompass Health Corporation has a 1 year low of $87.85 and a 1 year high of $127.99. The firm’s 50-day simple moving average is $119.72 and its 200-day simple moving average is $119.38. The firm has a market cap of $11.37 billion, a PE ratio of 21.36, a price-to-earnings-growth ratio of 2.02 and a beta of 0.73.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. Encompass Health had a return on equity of 17.84% and a net margin of 9.33%.The firm had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Equities analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a dividend of $0.19 per share. The ex-dividend date is Friday, January 2nd. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is 14.37%.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on EHC shares. UBS Group lifted their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, October 2nd. Bank of America boosted their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. KeyCorp raised their target price on Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research note on Tuesday, September 16th. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, November 23rd. Finally, Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Two analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $142.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.